A Systematic Review and Meta-Analysis on the Association Between Androgenic Alopecia and the Risk of Metabolic Syndrome; [Uma Revisao Sistematica E Metanalise Sobre a Associacao Entre Alopecia Androgenetica E O Risco De Sindrome Metabolica]

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

A Systematic Review and Meta-Analysis on the Association Between Androgenic Alopecia and the Risk of Metabolic Syndrome; [Uma Revisao Sistematica E Metanalise Sobre a Associacao Entre Alopecia Androgenetica E O Risco De Sindrome Metabolica] Publisher

Sadeghzadehbazargan A¹ ; Roohaninasab M¹ ; Seirafianpour F² ; Shemshadi M¹ ; Mohammadi A² ; Mozafarpoor S³ ; Goodarzi A¹

Source: Surgical and Cosmetic Dermatology Published:2022

Abstract

This study conducted a systematic review of studies on the relationship between androgenic alopecia and metabolic syndrome. We performed a comprehensive review of databases including PubMed, Web of Knowledge, Google Scholar, Scopus, and Embase, and extracted relevant articles published from 2010 to 2018. The case reports, review articles, or studies lacking full-text articles were excluded. We examined nine studies for the meta-analysis step. The results showed a significant relationship between alopecia and metabolic syndrome (OR = 2.81; CI 95% = 2.16-3.66; I2 = 73%; P = 0.0003). There is a significant correlation between androgenic alopecia and metabolic syndrome. © 2022, Surgical and Cosmetic Dermatology. All Rights Reserved.

Related Docs

View other Related Docs

1. Comparison of Androgenic Alopecia Distribution Among Type 2 Diabetes and Healthy Women in Isfahan City: A Brief Report, Tehran University Medical Journal (2014)

2. Skin and Metabolic Syndrome: A Review of the Possible Associations, Journal of Research in Medical Sciences (2021)

3. The Relationship of Androgenic Alopecia and Opium Consumption in Men: A Comparative Study, Journal of Isfahan Medical School (2017)

Experts (# of related papers)

View all Related Experts

Mina Saber (5)

Gita Faghihi (4)

Other Related Docs

4. Prevalence of Androgenic Alopecia in Women of 20-70 Years in Isfahan During 2008-2009, Journal of Pakistan Association of Dermatologists (2010)

5. Effectiveness of Oral Tofacitinib Treatment on Patients With Moderate-To-Severe Alopecia Areata in Iran, Journal of Cosmetic Dermatology (2024)

6. Inverse Correlation Between Vitamin D and Crp Levels in Alopecia Areata: A Pilot Study, Journal of Cosmetic Dermatology (2023)

7. Hirsutism and Body Mass Index in a Representative Sample of Iranian People, Journal of Isfahan Medical School (2014)

8. Comparison of the Therapeutic Effects of 5% Minoxidil Solution Alone With the Medicinal Combination of 5% Minoxidil and 0.005% Latanoprost in Men With Androgenetic Alopecia Referred to Skin Clinics of Isfahan University of Medical Sciences; [مقایسهی اثرات درمانی محلول ماینوکسیدیل 5 % به تنهایی با ترکیب دارویی ماینوکسیدیل 5 % و لاتانوپروست 005 / 0 % در مردان مبتلا به آلوپسی آندروژنتیک مراجعهکننده به درمانگاههای پوست دانشگاه علوم پزشکی اصفهان], Journal of Isfahan Medical School (2024)

9. Hair Loss and Metabolic and Bariatric Surgery: An Updated Systematic Review and Meta-Analysis, Obesity Surgery (2025)

10. The Simultaneous Occurrence of Lichen Planopilaris and Alopecia Areata: A Report of Two Cases and Literature Review, Clinical Case Reports (2020)

11. Evaluation of the Effects of Adding an Adipose Tissue-Derived Stromal Vascular Fraction to Platelet-Rich Plasma Injection in the Treatment of Androgenetic Alopecia: A Randomized Clinical Trial, Skin Research and Technology (2024)

12. Oral Pulse Betamethasone, Methotrexate, and Combination Therapy to Treat Severe Alopecia Areata: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial, Iranian Journal of Pharmaceutical Research (2021)

13. Hirsutism and Body Mass Index in a Representative Sample of Iranian People, ARYA Atherosclerosis (2012)

14. Comparison of Systemic and Topical Isotretinoin in the Treatment of Facial Lichen Planopilaris: A Randomized Controlled Trial, Journal of Cosmetic Dermatology (2022)

15. Clinical Effectiveness of Finasteride Versus Hydroxychloroquine in the Treatment of Frontal Fibrosing Alopecia: A Randomized Controlled Trial, Journal of Cosmetic Dermatology (2024)

16. Clinical Efficacy and Safety of Low-Dose Oral Minoxidil Versus Topical Solution in the Improvement of Androgenetic Alopecia: A Randomized Controlled Trial, Journal of Cosmetic Dermatology (2024)

17. Comparison Between “5% Minoxidil Plus 2% Flutamide” Solution Vs. “5% Minoxidil” Solution in the Treatment of Androgenetic Alopecia, Journal of Cosmetic Dermatology (2022)

18. The Impact of Recent Life Events on Patients With Alopecia Areata: A Study From Iran, Journal of Isfahan Medical School (2012)

19. Comparison of the Efficacy of Topical Minoxidil 5% and Adenosine 0.75% Solutions on Male Androgenetic Alopecia and Measuring Patient Satisfaction Rate, Acta Dermatovenerologica Croatica (2013)

20. Prevalence of Dermatologic Features in Patients With Ischemic Heart Disease, Shiraz E Medical Journal (2015)

Style	Citing Format
MLA	Sadeghzadehbazargan A, et al.. "A Systematic Review and Meta-Analysis on the Association Between Androgenic Alopecia and the Risk of Metabolic Syndrome; [Uma Revisao Sistematica E Metanalise Sobre a Associacao Entre Alopecia Androgenetica E O Risco De Sindrome Metabolica]." Surgical and Cosmetic Dermatology, vol. 14, no. , 2022, pp. -.
APA	Sadeghzadehbazargan A, Roohaninasab M, Seirafianpour F, Shemshadi M, Mohammadi A, Mozafarpoor S, Goodarzi A (2022). A Systematic Review and Meta-Analysis on the Association Between Androgenic Alopecia and the Risk of Metabolic Syndrome; [Uma Revisao Sistematica E Metanalise Sobre a Associacao Entre Alopecia Androgenetica E O Risco De Sindrome Metabolica]. Surgical and Cosmetic Dermatology, 14(), -.
Chicago	Sadeghzadehbazargan A, Roohaninasab M, Seirafianpour F, Shemshadi M, Mohammadi A, Mozafarpoor S, Goodarzi A. "A Systematic Review and Meta-Analysis on the Association Between Androgenic Alopecia and the Risk of Metabolic Syndrome; [Uma Revisao Sistematica E Metanalise Sobre a Associacao Entre Alopecia Androgenetica E O Risco De Sindrome Metabolica]." Surgical and Cosmetic Dermatology 14, no. (2022): -.
Harvard	Sadeghzadehbazargan A et al. (2022) 'A Systematic Review and Meta-Analysis on the Association Between Androgenic Alopecia and the Risk of Metabolic Syndrome; [Uma Revisao Sistematica E Metanalise Sobre a Associacao Entre Alopecia Androgenetica E O Risco De Sindrome Metabolica]', Surgical and Cosmetic Dermatology, 14(), pp. -.
Vancouver	Sadeghzadehbazargan A, Roohaninasab M, Seirafianpour F, Shemshadi M, Mohammadi A, Mozafarpoor S, et al.. A Systematic Review and Meta-Analysis on the Association Between Androgenic Alopecia and the Risk of Metabolic Syndrome; [Uma Revisao Sistematica E Metanalise Sobre a Associacao Entre Alopecia Androgenetica E O Risco De Sindrome Metabolica]. Surgical and Cosmetic Dermatology. 2022;14():-.
BibTex	@article{ author = {Sadeghzadehbazargan A and Roohaninasab M and Seirafianpour F and Shemshadi M and Mohammadi A and Mozafarpoor S and Goodarzi A}, title = {A Systematic Review and Meta-Analysis on the Association Between Androgenic Alopecia and the Risk of Metabolic Syndrome; [Uma Revisao Sistematica E Metanalise Sobre a Associacao Entre Alopecia Androgenetica E O Risco De Sindrome Metabolica]}, journal = {Surgical and Cosmetic Dermatology}, volume = {14}, number = {}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Sadeghzadehbazargan A AU - Roohaninasab M AU - Seirafianpour F AU - Shemshadi M AU - Mohammadi A AU - Mozafarpoor S AU - Goodarzi A TI - A Systematic Review and Meta-Analysis on the Association Between Androgenic Alopecia and the Risk of Metabolic Syndrome; [Uma Revisao Sistematica E Metanalise Sobre a Associacao Entre Alopecia Androgenetica E O Risco De Sindrome Metabolica] JO - Surgical and Cosmetic Dermatology VL - 14 IS - SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Abstract